Western society is at the brink of an atrial fibrillation (AF) explosion. Already AF is the most common sustained arrhythmia worldwide; in the US alone the estimated prevalence in 2010 was between 2.7 to 6.1 million, and this is expected to rise to between 5.6 and 12 million by 2050 [1] . The source of this increase is multifactorial and our current ability to manage the condition is often suboptimal. With this in mind we present this dozen of current "hot potatoes" in AF from epidemiology through management to, dare we say it foremost given our current economic climate, the cost implications of our management decisions.
